Show simple item record

dc.contributor.authorWilm, Anke
dc.contributor.authorGarcia de Lomana, Marina
dc.contributor.authorStork, Conrad
dc.contributor.authorMathai, Neann Sarah
dc.contributor.authorHirte, Steffen
dc.contributor.authorNorinder, Ulf
dc.contributor.authorKühl, Jochen
dc.contributor.authorKirchmair, Johannes
dc.date.accessioned2022-03-29T11:04:28Z
dc.date.available2022-03-29T11:04:28Z
dc.date.created2022-02-01T13:42:14Z
dc.date.issued2021
dc.identifier.issn1424-8247
dc.identifier.urihttps://hdl.handle.net/11250/2988303
dc.description.abstractIn recent years, a number of machine learning models for the prediction of the skin sensitization potential of small organic molecules have been reported and become available. These models generally perform well within their applicability domains but, as a result of the use of molecular fingerprints and other non-intuitive descriptors, the interpretability of the existing models is limited. The aim of this work is to develop a strategy to replace the non-intuitive features by predicted outcomes of bioassays. We show that such replacement is indeed possible and that as few as ten interpretable, predicted bioactivities are sufficient to reach competitive performance. On a holdout data set of 257 compounds, the best model (“Skin Doctor CP:Bio”) obtained an efficiency of 0.82 and an MCC of 0.52 (at the significance level of 0.20). Skin Doctor CP:Bio is available free of charge for academic research. The modeling strategies explored in this work are easily transferable and could be adopted for the development of more interpretable machine learning models for the prediction of the bioactivity and toxicity of small organic compounds.en_US
dc.language.isoengen_US
dc.publisherMDPIen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titlePredicting the Skin Sensitization Potential of Small Molecules with Machine Learning Models Trained on Biologically Meaningful Descriptorsen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2021 The Author(s)en_US
dc.source.articlenumber790en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doihttps://doi.org/10.3390/ph14080790
dc.identifier.cristin1996352
dc.source.journalPharmaceuticalsen_US
dc.identifier.citationPharmaceuticals. 2021, 14, 790.en_US
dc.source.volume14en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal